Novo Nordisk lifts 2024 outlook on weight-loss drug demand

Danish pharma giant Novo Nordisk lifted its 2024 outlook on Thursday and delivered better-than-expected first quarter profits as the company races to boost...

Related Keywords

United States ,Poland ,United Kingdom ,Germany ,Denmark ,Britain ,Danish ,Eli Lilly ,Lars Fruergaard Jorgensen ,Markus Manns ,Karsten Munk Knudsen ,Union Investment ,Reuters ,Novo Nordisk ,Fruergaard Jorgensen ,Chief Financial Officer Karsten Munk Knudsen ,Pharmaceutical Sector ,Pharma Industry ,Sales ,Wegovy ,